Have a feature idea you'd love to see implemented?
Let us know!
ABVC Abvc Biopharma Inc
Price (delayed)
$0.5412
Market cap
$7.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.86
Enterprise value
$8.58M
Highlights
Abvc Biopharma's EPS has surged by 76% YoY and by 48% QoQ
The gross margin has surged by 72% year-on-year
The quick ratio has declined by 46% year-on-year but it is up by 3.1% since the previous quarter
The revenue has declined by 31% year-on-year
ABVC's equity is down by 8% year-on-year
Key stats
What are the main financial stats of ABVC
Market
Valuations
Earnings
Shares outstanding
12.98M
Market cap
$7.02M
Enterprise value
$8.58M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.8
Price to sales (P/S)
13.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.83
Revenue
$509,788
Gross profit
$369,819
Net income
-$8.24M
EBIT
-$5.91M
EBITDA
-$5.88M
Free cash flow
-$1.79M
Per share
Balance sheet
Liquidity
EPS
-$0.86
EPS diluted
-$0.86
Free cash flow per share
-$0.14
Book value per share
$0.67
Revenue per share
$0.04
TBVPS
$1.17
Total assets
$14.46M
Total liabilities
$6.48M
Debt
$2.33M
Equity
$8.36M
Working capital
-$4.17M
Debt to equity
0.28
Current ratio
0.34
Quick ratio
0.33
Net debt/EBITDA
-0.26
Margins
Efficiency
Dividend
EBITDA margin
-1,153.7%
Gross margin
72.5%
Net margin
-1,617%
Operating margin
-1,242.2%
Return on assets
-56.8%
Return on equity
-100.4%
Return on invested capital
-60.4%
Return on capital employed
-72.6%
Return on sales
-1,159.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ABVC stock price
How has the Abvc Biopharma stock price performed over time
Intraday
0.22%
1 week
4.94%
1 month
3.28%
1 year
-56.7%
YTD
-8.27%
QTD
-8.27%
Financial performance
How have Abvc Biopharma's revenue and profit performed over time
Revenue
$509,788
Gross profit
$369,819
Operating income
-$6.33M
Net income
-$8.24M
Gross margin
72.5%
Net margin
-1,617%
The net margin has soared by 81% from the previous quarter and by 2.6% YoY
The operating margin has soared by 80% since the previous quarter and by 2.2% year-on-year
The gross margin has surged by 72% year-on-year
ABVC's net income is up by 33% year-on-year and by 28% since the previous quarter
Growth
What is Abvc Biopharma's growth rate over time
Valuation
What is Abvc Biopharma stock price valuation
P/E
N/A
P/B
0.8
P/S
13.17
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
16.83
Abvc Biopharma's EPS has surged by 76% YoY and by 48% QoQ
The P/B is 33% less than the last 4 quarters average of 1.2
ABVC's equity is down by 8% year-on-year
The P/S is 91% lower than the last 4 quarters average of 154.2
The revenue has declined by 31% year-on-year
Efficiency
How efficient is Abvc Biopharma business performance
Abvc Biopharma's return on sales has surged by 80% QoQ and by 12% YoY
The company's return on equity has surged by 72% YoY and by 26% QoQ
The ROA has grown by 47% year-on-year and by 25% since the previous quarter
ABVC's ROIC is up by 44% YoY and by 19% QoQ
Dividends
What is ABVC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ABVC.
Financial health
How did Abvc Biopharma financials performed over time
ABVC's total assets is 123% greater than its total liabilities
The quick ratio has declined by 46% year-on-year but it is up by 3.1% since the previous quarter
ABVC's current ratio is down by 26% year-on-year but it is up by 3% since the previous quarter
The debt is 72% less than the equity
The debt has contracted by 32% YoY and by 3.5% from the previous quarter
The debt to equity has declined by 24% year-on-year and by 3.4% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.